- Home
- APDN
as 11-15-2024 4:00pm EST
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | STONY BROOK |
| Market Cap: | 3.3M | IPO Year: | N/A |
| Target Price: | $1.50 | AVG Volume (30 days): | 4.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.87 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.15 - $22.80 | Next Earning Date: | 12-05-2024 |
| Revenue: | $3,398,049 | Revenue Growth: | -78.96% |
| Revenue Growth (this year): | -73.17% | Revenue Growth (next year): | 48.01% |
Latest Applied DNA Sciences Inc. News
APDN Breaking Stock News: Dive into APDN Ticker-Specific Updates for Smart Investing
ACCESSWIRE
19 days ago
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
ACCESSWIRE
a month ago
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
GuruFocus.com
a month ago
Applied DNA Sciences Inc (APDN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines ...
MT Newswires
2 months ago
Applied DNA Regains Nasdaq Compliance With Minimum Bid Price Rule
ACCESSWIRE
2 months ago
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
ACCESSWIRE
2 months ago
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
ACCESSWIRE
2 months ago
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
MT Newswires
2 months ago
Sector Update: Health Care Stocks Retreat Late Afternoon
Compare APDN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APDN Applied DNA Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.